|
|
|
|
| LEADER |
01151caa a2200325 ir4500 |
| 001 |
NSK01000198882 |
| 003 |
HR-ZaNSK |
| 005 |
20070917132913.0 |
| 008 |
970924s1996 ci ||| ||eng |
| 015 |
|
|
|a HP96-3094
|2 HR
|
| 035 |
|
|
|9 (HR-ZaNSK)199093
|
| 035 |
|
|
|9 (HR-ZaNSK)970924017
|
| 035 |
|
|
|a (HR-ZaNSK)000198882
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 041 |
0 |
|
|a eng
|b hrv
|
| 080 |
|
|
|a 615.252.014
|
| 100 |
1 |
|
|a Ismail, Fatma Ahmed
|
| 245 |
1 |
0 |
|a Improvement of in vitro availability of glibenclamide via combination with non-porous fumed silicon dioxide /
|c Fatma Ahmed Ismail, Magda Abdel El Massik, Nabila Ahmed Boraie, Ossama Youssef Abdallah.
|
| 300 |
|
|
|b Ilustr.
|
| 504 |
|
|
|a Bibliografija: 23 jed
|
| 504 |
|
|
|a Sažetak
|
| 650 |
|
7 |
|a Glibenklamid
|x Proizvodnja
|2 nskps
|
| 700 |
1 |
|
|a El Massik, Magda Abdel
|
| 700 |
1 |
|
|a Boraie, Nabila Ahmed
|
| 700 |
1 |
|
|a Abdallah, Ossama Yuossef
|
| 773 |
0 |
|
|t Acta pharmaceutica (Zagreb)
|x 1330-0075
|g 46 (1996), 3 ; str. 229-238
|w nsk.(HR-ZaNSK)000054908
|
| 932 |
|
|
|a da
|b znanstveni rad
|
| 981 |
|
|
|p CRO
|z B4-6/96
|
| 998 |
|
|
|c ikak9803
|c sbno9807
|
| 886 |
0 |
|
|2 unimarc
|b 00928iaa2 2200253 450
|